Publications and Investor Information

  1. Home
  2. >
  3. Publications and Investor Information

Scientific Publications

RESCAP® (rescuing alkaline phosphatase) is the proprietary name for our medication based on the enzyme alkaline phosphatase (AP), naturally present in the body and part of the innate immune system (‘first line of defence’).

The invention of alkaline phosphatase as a health relevant enzyme

Poelstra, K., Bakker, W.W., Klok, P.A., Kamps, J.A., Hardonk, M.J. and Meijer, D.K., 1997. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. The American journal of pathology, 151(4), p.1163.

Patient studies with RESCAP: Possible therapeutic strategies

Kats, S., Schönberger, J.P., Brands, R., Seinen, W. and van Oeveren, W., 2011. Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies. An update. European journal of cardio-thoracic surgery, 39(4), pp.451-458.

Patient studies with RESCAP: Safety and efficacy data

Keizer, H., Kats, S., Christis, I., Heylen, R., Oosting, R., Seinen, W. and Brands, R., Safety and efficacy data of a randomized, double-blind, placebo-controlled phase II study with the biological response modifier “bRESCAP” in patients undergoing cardiac surgery (APPIRED II).

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Kaliannan, K., Hamarneh, S.R., Economopoulos, K.P., Nasrin Alam, S., Moaven, O., Patel, P., Malo, N.S., Ray, M., Abtahi, S.M., Muhammad, N. and Raychowdhury, A., 2013. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proceedings of the National Academy of Sciences, 110(17), pp.7003-7008.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Kühn, F., Adiliaghdam, F., Cavallaro, P.M., Hamarneh, S.R., Tsurumi, A., Hoda, R.S., Munoz, A.R., Dhole, Y., Ramirez, J.M., Liu, E. and Vasan, R., 2020. Intestinal alkaline phosphatase targets the gut barrier to prevent aging. JCI insight, 5(6).

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Pickkers, P., Heemskerk, S., Schouten, J., Laterre, P.F., Vincent, J.L., Beishuizen, A., Jorens, P.G., Spapen, H., Bulitta, M., Peters, W.H. and van der Hoeven, J.G., 2012. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Critical care, 16, pp.1-12.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Davidson, J.A., Khailova, L., Treece, A., Robison, J., Soranno, D.E., Jaggers, J., Ing, R.J., Lawson, S. and Lujan, S.O., 2019. Alkaline phosphatase treatment of acute kidney injury in an infant piglet model of cardiopulmonary bypass with deep hypothermic circulatory arrest. Scientific reports, 9(1), p.14175.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Heemskerk, S., Masereeuw, R., Moesker, O., Bouw, M.P., van der Hoeven, J.G., Peters, W.H., Russel, F.G., Pickkers, P. and APSEP Study Group, 2009. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Critical care medicine, 37(2), pp.417-e1.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Santos, G.M., Ismael, S., Morais, J., Araújo, J.R., Faria, A., Calhau, C. and Marques, C., 2022. Intestinal alkaline phosphatase: A review of this enzyme role in the intestinal barrier function. Microorganisms, 10(4), p.746.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Adiliaghdam, F., Cavallaro, P., Mohad, V., Almpani, M., Kühn, F., Gharedaghi, M.H., Najibi, M., Rahme, L.G. and Hodin, R.A., 2020. Targeting the gut to prevent sepsis from a cutaneous burn. JCI insight, 5(19).

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Kahrovic, A., Poschner, T., Schober, A., Angleitner, P., Alajbegovic, L., Andreas, M., Hutschala, D., Brands, R., Laufer, G., & Wiedemann, D. 2023. “Increased Drop in Activity of Alkaline Phosphatase in Plasma from Patients with Endocarditis.” Int. J. Mol. Sci. 24(14): 11728.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Presbitero, A, E.Mancini, R.Brands, V.Krzhizhanovskaya, P. Sloot, Supplemented Alkaline Phosphatase Supports the Immune Response in Patients Undergoing Cardiac Surgery: Clinical and Computational Evidence Front. Immunol., 11 October 2018.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Anne-Kristin Schaefer, Doris Hutschala, Martin Andreas, Martin Bernardi, Ruud Brands, Shiva Shabanian, Günther Laufer, Dominik Wiedemann. Decrease in serum alkaline phosphatase and prognostic relevance in adult cardiopulmonary bypass.  Interactive CardioVascular and Thoracic Surgery (2020) 1–8.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Thomas Poschner, Anne-Kristin Schaefer, Doris Hutschal, Georg Goliasch, Klaus Distelmaier, Martin Bernardi, Martin Andreas, Ruud Brands, Günther Laufer and Dominik Wiedemann. Impact of veno-arterial extracorporeal membrane oxygenation on alkaline phosphatase metabolism after cardiac surgery. Biomolecules 2021, 11, 748.

Supportive literature on the potential of RESCAP® (alkaline phosphatase)

Vu T, Fricke TA, Smith JA. A Review of Alkaline Phosphatase in Preventing Systemic Inflammation after Cardiac Surgery. European Journal of Respiratory Medicine. 2021; 3:2.

 

Investor Information

News and Press Releases

Contact Us

Please take out a moment to fill this form and we will get back to you soon.

Upcoming Conferences